Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells

Immunological Investigations

Volumn 38, Issue 6, 2009, Pages 526-550

  Reynolds, Jessica L ^a   Mahajan, Supriya D ^a   Aalinkeel, Ravikunar ^a   Nair, B ^a   Sykes, Donald E ^a   Schwartz, Stanley A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cocaine; Difference gel electrophoresis (DIGE); High performance liquid chromatography tandem mass spectrometry (HPLC MSMS); Methamphetamine; Monocyte derived mature dendritic cells

Indexed keywords

COCAINE; METHAMPHETAMINE; PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DENDRITIC CELL; DRUG ABUSE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; DENDRITIC CELLS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MASS SPECTROMETRY; METHAMPHETAMINE; MONOCYTES; PROTEINS; PROTEOME; PROTEOMICS; SUBSTANCE-RELATED DISORDERS;

EID: 70350580814     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130902874110     Document Type: Article

References (97)

1. Amersham Pharmaceuticals, http://www1.amershambiosciences.com/aptrix/ upp00919.nsf/Content/Proteomics+DIGE+Protocols.
2. Ammosova, T., Jerebtsova, M., Beullens, M., Voloshin, Y., Ray, P. E., Kumar, A., Bollen, M., Nekhai, S. (2003). Nuclear protein phosphatase-1 regulates HIV-1 transcription. J. Biol. Chem. 278:32189-32194.
3. Ammosova, T., Washington, K., Debebe, Z., Brady, J., Nekhai, S. (2005). Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tatactivated HIV-1 transcription. Retrovirology 2:47.
4. Andon, N. L., Hollingworth, S., Koller, A., Greenland, A. J., Yates, J. R., Haynes, P. A. (2002). Proteomic characterization of wheat amyloplasts using identification of proteins by tandem mass spectrometry. Proteomics 2:1156-1168.
5. Ang, E., Chen, J., Zagouras, P., Magna, H., Holland, J., Schaeffer, E., Nestler, E. J. (2001). Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J. Neurochem. 79:221-224.
6. Ansari, S. A., Safak, M., Gallia, G. L., Sawaya, B. E., Amini, S., Khalili, K. (1999). Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. J. Gen. Virol. 80:2629-2638.
7. Bagasra, O., Forman, L. (1989). Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clin. Exp. Immunol. 77:289-293.
8. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trépo, C., Inchauspé, G. (2001). Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524.
9. Baldwin, G. C., Tashkin, D. P., Buckley, D. M., Park, A. N., Dubinett, S. M., Roth, M. D. (1997). Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156:1606-1613.
10. Banchereau, J., Steinman, R. M. (1998). DC and the control of immunity. Nature 392:245-252.
11. Bayer, B. M., Hernandez, M. C., Ding, X. Z. (1996). Tolerance and cross tolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation. Pharmacol. Biochem. Behav. 53:227-234.
12. Beinke, S., Ley, S. C. (2004). Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382:393-409.
13. Bender, A., Sapp, M., Schuler, G., Steinman, R. M., Bhardwaj, N. (1996). Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Meth. 196:121-135. (Pubitemid 26306734)
14. Berretta, M., Zanet, E., Di Benedetto, F., Simonelli, C., Bearz, A., Morra, A., Bonanno, S., Berretta, S., Tirelli, U. (2008). Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: case report and review of the literature. Tumori 94(4):589-591.
15. Breci, L., Hattrup, E., Keeler, M., Letarte, J., Johnson, R., Haynes, P. A. (2005). Comprehensive proteomics in yeast using chromatographic fractionation, gas phase fractionation, protein gel electrophoresis, and isoelectric focusing. Proteomics 5(8):2018-2028.
16. Celec, P. (2004). Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed. Pharmacother. 58:365-371.
17. Centers for Disease Control and Prevention (CDC). Coinfection with HIV and Hepatitis C Virus. November, 2005.
18. Cooper, B., Eckert, D., Andon, N. L., Yates, J. R., Haynes, P. A. (2003). Investigative proteomics: identification of an unknown plant virus from infected plants using mass spectrometry. J. Am. Soc. Mass Spectrom. 14:736-741.
19. Dauer, M., Obermaier, B., Herten, J., Haerle, C., Pohl, K., Rothenfusser, S., Schnurr, M., Endres, S., Eigler, A. (2003). Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J. Immunol. 170: 4069-4076.
20. Drug Abuse Warning Network (DAWN), http://dawninfo.samhsa.gov/files/ ED2006/DAWN2k6ED.pdf
21. Duong, F. H., Christen, V., Berke, J. M., Penna, S. H., Moradpour, D., Heim, M. H. (2005). Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. J. Virol. 79(24):15342-15350.
22. Edwards, D. J., Bowles, S. K. (1988). Protein binding of cocaine in human serum. Pharm. Res. 5:440-442.
23. El Messaoudi, K., Thiry, L., Van Tieghem, N., Liesnard, C., Englert, Y., Moguilevsky, N., Bollen, A. (1999). HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions. AIDS 13:333-339.
24. El Messaoudi, K., Thiry, L. F., Liesnard, C., Van Tieghem, N., Bollen, A., Moguilevsky, N. (2000). A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. J. Virol. 74:1004-1007.
25. Garderet, L., Cao, H., Salamero, J., Vergé, V., Tisserand, E., Scholl, S., Gorin, N. C., Lopez, M. (2001). In vitro production of dendritic cells from human blood monocytes for therapeutic use. J. Hematother. Stem Cell Res. 10(4):553-567.
26. Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S., Mische, S. M. (1999). Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601-605.
27. Granelli-Piperno, A., Delgado, E., Finkel, V., Paxton, W., Steinman, R. M. (1998). Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72:2733-2737.
28. Gullo, C. A., Teoh, G. (2004). Heat shock proteins: to present or not, that is the question. Immunol. Lett. 94:1-10.
29. Haines, K. A., Reibman, J., Callegari, P. E., Abramson, S. B., Philips, M. R., Weissmann, G. (1990). Cocaine and its derivatives blunt neutrophil functions without influencing phosphorylation of a 47-kilodalton component of the reduced nicotinamide-adenine dinucleotide phosphate oxidase. J. Immunol. 144(12):4757-4764.
30. Hargrave, B. Y., Tiangco, D. A., Lattanzio, F. A., Beebe, S. J. (2003). Cocaine, not morphine, causes the generation of reactive oxygen species and activation of NF-kappaB in transiently cotransfected heart cells. Cardiovasc. Toxicol. 3:141-151.
31. Haynes, P. A., Gygi, S. P., Figeys, D., Aebersold, R. (1998). Proteome analysis: biological assay or data archive? Electrophoresis 19:1862-1871.
32. Holm, P. S., Bergmann, S., Jurchott, K., Lage, H., Brand, K., Ladhoff, A., Mantwill, K., Curiel, D. T., Dobbelstein, M., Dietel, M., Gansbacher, B., Royer, H. D. (2002). YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter. J. Biol. Chem. 277(12):10427-10434.
33. Jacque, J. M., Mann, A., Enslen, H., Sharova, N., Brichacek, B., Davis, R. J., Stevenson, M. (1998). Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17:2607-2618.
34. Johnson, G. L., Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
35. Kalasinsky, K. S., Bosy, T. Z., Schmunk, G. A., Reiber, G., Anthony, R. M., Furukawa, Y., Guttman, M., Kish, S. J. (2001). Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic Sci. Int. 116:163-169.
36. Kan, H., Xie, Z., Finkel, M. S. (2004). p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes. Am. J. Physiol. Cell Physiol. 286:C1-7.
37. Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., Hori, M. (1999). Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162:5584-5591.
38. Kanto, T., Inoue, M., Miyatake, H., Sato, A., Sakakibara, M., Yakushijin, T., Oki, C., Itose, I., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N. (2004). Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190:1919-1926.
39. Kashanchi, F., Duvall, J. F., Dittmer, J., Mireskandari, A., Reid, R. L., Gitlin, S. D., Brady, J. N. (1994). Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression. J. Virol. 68:561-565.
40. Kim, J. H., Psevdos, G., Suh, J., Sharp, V. L. (2008). Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World J. Gastroenterol. 14(43):6689-6693.
41. Kohno, K., Izumi, H., Uchiumi, T., Ashizuka, M., Kuwano, M. (2003). The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25:691-698.
42. Kumar, A., Manna, S. K., Dhawan, S., Aggarwal, B. B. (1998). HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161:776-781.
43. Lee, Y. W., Hennig, B., Yao, J., Toborek, M. (2001). Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J. Neurosci. Res. 66:583-591.
44. Liang, H., Wang, X., Chen, H., Song, L., Ye, L., Wang, S. H., Wang, Y. J., Zhou, L., Ho, W. Z. (2008). Methamphetamine enhances HIV infection of macrophages. Am. J. Pathol. 172(6):1617-1624.
45. Lilley, K. S., Friedman D. B. (2004). All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev. Proteomics. 1:401-409.
46. Lo, P. (2003). HIV hijacks dendritic cells. Nat. Med. 9(6):650.
47. Loré, K., Smed-Sörensen, A., Vasudevan, J., Mascola, J. R., Koup, R. A. (2005). Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J. Exp. Med. 201:2023-2033.
48. Mahajan, S. D., Hu, Z., Reynolds, J. L., Aalinkeel, R., Schwartz, S. A., Nair, M. P. (2006). Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol. Diagn. Ther. 10(4):257-269.
49. Matthews, G. V., Dore, G. J. (2008). HIV and hepatitis C coinfection. J. Gastroenterol. Hepatol. 23(7 Pt 1):1000-1008.
50. McDonald, D., Wu, L., Bohks, S. M., Kewal Ramani, V. M., Unutmaz, D., Hope, T. J. (2003). Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300:1295-1297.
51. McElhinny, J. A., MacMorran, W. S., Bren, G. D., Ten, R. M., Israel, A., Paya, C. V. (1995). Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J. Virol. 69:1500-1509.
52. Mohamadzadeh, M., Duong, T., Hoover, T., Klaenhammer, T. R. (2008). Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev. Vaccines 7(2):163-174.
53. Moris, A., Nobile, C., Buseyne, F., Porrot, F., Abastado, J. P., Schwartz, O. (2004). DCSIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103:2648-2654.
54. Mukunda, B. N., Callahan, J. M., Hobbs, M. S., West, B. C. (2000). Cocaine inhibits human neutrophil phagocytosis and phagolysosomal acidification in vitro. Immunopharmacol. Immunotoxicol. 22(2):373-386.
55. Muthumani, K., Wadsworth, S. A., Dayes, N. S., Hwang, D. S., Choo, A. Y., Abeysinghe, H. R., Siekierka, J. J., Weiner, D. B. (2004). Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor. AIDS 18:739-748.
56. Nair, M. P., Mahajan, S., Sykes, D., Bapardekar, M. V., Reynolds, J. L. (2006). Methamphetamine modulates DC-SIGN expression by mature dendritic cells. J. Neuroimmune Pharmacol. 1(3):296-304.
57. Nair, M. P. N., Mahajan, S. D., Schwartz, S. A., Reynolds, J., Whitney, R., Berstein, Z., Chawda, R. P., Sykes, D., Hewett, R., Hsiao, C. B. (2005). Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J. Immunol. 174:6617-6626.
58. Navas, M. C., Fuchs, A., Schvoerer, E., Bohbot, A., Aubertin, A. M., Stoll-Keller, F. (2002) Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. J. Med. Virol. 67(2):152-161.
59. NIDA (National Institute of Drug Abuse) INFO FACTS, Methamphetamine, accessed May 2005 from http://www.drugabuse.gov/Infofacts/Infofaxindex.html.
60. Nishimoto, S., Nishida. E. (2006). MAPK signaling: ERK5 versus ERK1/2. EMBO Rep. 7:782-786.
61. Okamoto, T., Nishimura, Y., Ichimura, T., Suzuki, K., Miyamura, T., Suzuki, T., Moriishi, K., Matsuura, Y. (2006). Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J. 25(20):5015-5025.
62. Pachiadakis, I., Pollara, G., Chain, B. M., Naoumov, N. V. (2005). Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect. Dis. 5(5):296-304.
63. Parodi, C., Belmonte, L., Baré P., de Bracco, M. M., Ruibal-Ares, B. (2007). Impact of human immune deficiency virus infection on hepatitis C virus infection and replication. Curr. HIV Res. 5(1):55-67.
64. Pellegrino, T. C., Dunn, K. L., Bayer, B. M. (2001). Mechanisms of cocaine-induced decreases in immune cell function. Int. Immunopharmacol. 1:665-675.
65. Piguet, V., Steinman, R. M. (2007). The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 228(11):503-510.
66. Poet, T. S., Pillai, R., Wood, S., Watson, R. R. (1991). Stimulation of natural killer cell activity by murine retroviral infection and cocaine. Toxicol. Lett. 59(1-3):147-152.
67. Prin-Mathieu, C., Baty, V., Faure, G., Schumacher, H., Kolopp-Sarda, M. N., May, T., Canton, P., Bene, M. C. (2001). Assessment by flow cytometry of peripheral blood leukocyte enzymatic activities in HIV patients. J. Immunol. Meth. 252:139-146.
68. Prohaszka, Z., Fust, G. (2004). Immunological aspects of heat-shock proteins-the optimum stress of life. Mol. Immunol. 41:29-44.
69. Reis e Sousa, C. (2006). Dendritic cells in a mature age. Nat Rev. Immunol. 6:476-483.
70. Reynolds, J. L., Mahajan, S. D., Sykes, D. E., Schwartz, S. A., Nair, M. P. (2007). Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim. Biophys. Acta 1774(4):433-442.
71. Riese, R. J., Chapman, H. A. (2000). Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12:107-113.
72. Robichaud, G. A., Poulin, L. (2000). HIV type 1 nef gene inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the action of MAPK and JNK in human glial cells. AIDS Res. Hum. Retrovir. 16:1959-1965.
73. Rusnati, M., Urbinati, C., Musulin, B., Ribatti, D., Albini, A., Noonan, D., Marchisone, C., Waltenberger, J., Presta, M. (2001). Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium 8(1):65-74.
74. Safak, M., Sadowska, B., Barrucco, R., Khalili, K. (2002). Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 76:3828-3838.
75. Sanders, R. W., de Jong, E. C., Baldwin, C. E., Schuitemaker, J. H., Kapsenberg, M. L., Berkhout, B. (2002). Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76: 7812-7821.
76. Sato, Y., Kato, J., Takimoto, R., Takada, K., Kawano, Y., Miyanishi, K., Kobune, M., Sato, Y., Takayama, T., Matunaga, T., Niitsu, Y. (2006). Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut. 55(12):1801-1808.
77. Schepers, R. J. F, Oyler, J. M., Joseph, R. E., Cone, E. J., Moolchan, E. T., Huestis, M. A. (2003). Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 49:121-132.
78. Schramm, W., Craig, P. A., Smith, R. H., Berger, G. E. (1993). Cocaine and benzoylecgonine in saliva, serum, and urine. Clin. Chem. 39:481-487.
79. Shively, L., Chang, L., LeBon, J. M., Liu, Q., Riggs, A. D., Singer-Sam, J. (2003). Realtime PCR assay for quantitative mismatch detection. Biotechniques 34:498-502.
80. Steinman, R. M., Banchereau, J. (2007) Taking dendritic cells into medicine. Nature 449(7161):419-426.
81. Substance Abuse and Mental Health Services Administration SAMSHA), September 2007.
82. Takayasu, T., Ohshima, T., Nishigami, J., Kondo, T., Nagaon T. (1995). Screening and determination of methamphetamine and amphetamine in the blood, urine and stomach contents in emergency medical care and autopsy cases. J. Clin. Forens. Med. 2:25-33.
83. Tallóczy, Z., Martinez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., Mizushima, N., Nosanchuk, J., Goldstein, H., Loike, J., Sulzer, D., Santambrogio, L. (2008). Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 4(2):e28.
84. Thein, H. H., Yi, Q., Dore, G. J., Krahn, M. D. (2008). Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 22(15):1979-1991.
85. Tscherne, D. M., Jones, C. T., Evans, M. J., Lindenbach, B. D., McKeating, J. A., Rice, C. M. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. (2006). J. Virol. 80(4):1734-1741.
86. UNODC, http://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html.
87. Van Dyke, C., Stesin, A., Jones, R., Chuntharapai, A., Seaman, W. (1986). Cocaine increases natural killer cell activity. J. Clin. Invest. 77(4):1387-1390.
88. Wainberg, Z., Oliveira, M., Lerner, S., Tao, Y., Brenner, B. G. (1997). Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Virology 233:364-373.
89. Wessel, D., Flugge, U. I. (1984). Method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:141-143.
90. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., Mann, M. (1996). Femtomole sequencing of proteins from polyacrylamide gels by nanoelectrospray mass spectrometry. Nature 379:466-469.
91. Wolffe, A. P. (1994). Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays 6:245-251.
92. Ye, L., Peng, J. S., Wang, X., Wang, Y. J., Luo, G. X., Ho, W. Z. (2008). Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J. Viral. Hepat. 15(4):261-270.
93. Yu, H. J., Reuter, M. A., McDonald, D. (2008) HIV traffics through a specialized, surfaceaccessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog. 4:100-134.
94. Zhao, L. J., Wang, L., Ren, H., Cao, J., Li, L., Ke, J. S., Qi, Z. T. (2005). Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ ERK signaling pathway via cellular receptors. Exp. Cell Res. 305(1):23-32.
95. Zhao, L. J., Zhang, X. L., Zhao, P., Cao, J., Cao, M. M., Zhu, S. Y., Liu, H. Q., Qi, Z. T. (2006). Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J. Leukoc. Biol. 80(2):424-432.
96. Zhao, L. J., Zhao, P., Chen, Q. L., Ren, H., Pan, W., Qi, Z. T. (2007). Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection. Cell Prolif. 40(4):508-521.
97. Zolnierowicz, S. (2000). Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem. Pharmacol. 60:1225-1235.